Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Non Operating Income: 2018-2024

Historic Non Operating Income for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $3.8 million.

  • Whitehawk Therapeutics' Non Operating Income rose 107.61% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.8 million, marking a year-over-year increase of 1946.83%. This contributed to the annual value of $3.8 million for FY2024, which is 38.93% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Non Operating Income is $3.8 million, which was down 38.93% from $6.2 million recorded in FY2023.
  • Over the past 5 years, Whitehawk Therapeutics' Non Operating Income peaked at $6.2 million during FY2023, and registered a low of -$927,000 during FY2020.
  • Over the past 3 years, Whitehawk Therapeutics' median Non Operating Income value was $3.8 million (recorded in 2024), while the average stood at $4.0 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Non Operating Income plummeted by 178.99% in 2020, and later soared by 221.79% in 2021.
  • Yearly analysis of 5 years shows Whitehawk Therapeutics' Non Operating Income stood at -$927,000 in 2020, then skyrocketed by 221.79% to $1.1 million in 2021, then soared by 92.03% to $2.2 million in 2022, then skyrocketed by 184.50% to $6.2 million in 2023, then slumped by 38.93% to $3.8 million in 2024.